These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16773269)

  • 1. Leg muscle involvement in facioscapulohumeral muscular dystrophy assessed by MRI.
    Olsen DB; Gideon P; Jeppesen TD; Vissing J
    J Neurol; 2006 Nov; 253(11):1437-41. PubMed ID: 16773269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Muscle Testing Compared with Whole-Body Magnetic Resonance Imaging in Facio-scapulo-humeral Muscular Dystrophy.
    Regula JU; Jestaedt L; Jende F; Bartsch A; Meinck HM; Weber MA
    Clin Neuroradiol; 2016 Dec; 26(4):445-455. PubMed ID: 25860436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle MRI findings in facioscapulohumeral muscular dystrophy.
    Gerevini S; Scarlato M; Maggi L; Cava M; Caliendo G; Pasanisi B; Falini A; Previtali SC; Morandi L
    Eur Radiol; 2016 Mar; 26(3):693-705. PubMed ID: 26115655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adding quantitative muscle MRI to the FSHD clinical trial toolbox.
    Mul K; Vincenten SCC; Voermans NC; Lemmers RJLF; van der Vliet PJ; van der Maarel SM; Padberg GW; Horlings CGC; van Engelen BGM
    Neurology; 2017 Nov; 89(20):2057-2065. PubMed ID: 29030457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leg Muscle Involvement in Facioscapulohumeral Muscular Dystrophy: Comparison between Facioscapulohumeral Muscular Dystrophy Types 1 and 2.
    Mair D; Huegens-Penzel M; Kress W; Roth C; Ferbert A
    Eur Neurol; 2017; 77(1-2):32-39. PubMed ID: 27855411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe paraspinal muscle involvement in facioscapulohumeral muscular dystrophy.
    Dahlqvist JR; Vissing CR; Thomsen C; Vissing J
    Neurology; 2014 Sep; 83(13):1178-83. PubMed ID: 25142899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration.
    Janssen BH; Voet NB; Nabuurs CI; Kan HE; de Rooy JW; Geurts AC; Padberg GW; van Engelen BG; Heerschap A
    PLoS One; 2014; 9(1):e85416. PubMed ID: 24454861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Skeletal muscle MRI of lower limbs in patients with facioscapulohumeral dystrophy].
    Ma MM; Song J; Zhang JW; Gao L; Pang M; Li G; Fu J
    Zhonghua Yi Xue Za Zhi; 2019 Mar; 99(9):675-679. PubMed ID: 30831616
    [No Abstract]   [Full Text] [Related]  

  • 9. Ultrasound pattern of anterolateral leg muscles in facioscapulohumeral muscular dystrophy.
    Veltsista D; Chroni E
    Acta Neurol Scand; 2021 Aug; 144(2):216-220. PubMed ID: 33844852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients.
    Andersen G; Dahlqvist JR; Vissing CR; Heje K; Thomsen C; Vissing J
    J Neurol; 2017 Mar; 264(3):438-447. PubMed ID: 28000006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy.
    Kan HE; Scheenen TW; Wohlgemuth M; Klomp DW; van Loosbroek-Wagenmans I; Padberg GW; Heerschap A
    Neuromuscul Disord; 2009 May; 19(5):357-62. PubMed ID: 19329315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative
    Gerhalter T; Marty B; Gast LV; Porzelt K; Heiss R; Uder M; Schwab S; Carlier PG; Nagel AM; Türk M
    J Neurol; 2021 Mar; 268(3):1076-1087. PubMed ID: 33047224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Camptocormia phenotype of FSHD: a clinical and MRI study on six patients.
    Jordan B; Eger K; Koesling S; Zierz S
    J Neurol; 2011 May; 258(5):866-73. PubMed ID: 21165637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Only fat infiltrated muscles in resting lower leg of FSHD patients show disturbed energy metabolism.
    Kan HE; Klomp DW; Wohlgemuth M; van Loosbroek-Wagemans I; van Engelen BG; Padberg GW; Heerschap A
    NMR Biomed; 2010 Jul; 23(6):563-8. PubMed ID: 20175146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between muscle involvement, phenotype and D4Z4 fragment size in facioscapulohumeral muscular dystrophy.
    Wang CH; Leung M; Liang WC; Hsieh TJ; Chen TH; Jong YJ
    Neuromuscul Disord; 2012 Apr; 22(4):331-8. PubMed ID: 22153988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle fibrosis as a prognostic biomarker in facioscapulohumeral muscular dystrophy: a retrospective cohort study.
    Ragozzino E; Bortolani S; Di Pietro L; Papait A; Parolini O; Monforte M; Tasca G; Ricci E
    Acta Neuropathol Commun; 2023 Oct; 11(1):165. PubMed ID: 37849014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative muscle ultrasound versus quantitative magnetic resonance imaging in facioscapulohumeral dystrophy.
    Janssen BH; Pillen S; Voet NB; Heerschap A; van Engelen BG; van Alfen N
    Muscle Nerve; 2014 Dec; 50(6):968-75. PubMed ID: 24659533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle Quantitative MR Imaging and Clustering Analysis in Patients with Facioscapulohumeral Muscular Dystrophy Type 1.
    Lareau-Trudel E; Le Troter A; Ghattas B; Pouget J; Attarian S; Bendahan D; Salort-Campana E
    PLoS One; 2015; 10(7):e0132717. PubMed ID: 26181385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle Microdialysis to Investigate Inflammatory Biomarkers in Facioscapulohumeral Muscular Dystrophy.
    Tasca G; Monforte M; Corbi M; Granata G; Lucchetti D; Sgambato A; Ricci E
    Mol Neurobiol; 2018 Apr; 55(4):2959-2966. PubMed ID: 28456937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body magnetic resonance imaging evaluation of facioscapulohumeral muscular dystrophy.
    Leung DG; Carrino JA; Wagner KR; Jacobs MA
    Muscle Nerve; 2015 Oct; 52(4):512-20. PubMed ID: 25641525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.